Peptide Receipt
PT-141 · Checked 2026-07-25
PR-DRAFT-MS09S37U
Claim
“PT-141 increases libido”
What people are actually reporting
Anecdotal · User-reported · Not clinical evidence
Here’s what keeps coming up in real user reports:
- increased sexual desire
- central nervous system action
- on-demand usage
- nausea side effects
LESS CONSISTENT REPORTS
- Reports of flushing or facial redness.
- Some users find the timing of the effects to be unpredictable.
The receipt
Supported
Confidence · High
Yes. PT-141 (known medically as bremelanotide) is a melanocortin receptor agonist that works via the central nervous system to increase sexual desire.
What the research says
Current research confirms that bremelanotide modulates the melanocortin receptors (MC3R and MC4R) to influence the brain's reward and desire systems. Large trials have shown it increases desire and reduces the distress associated with low libido.
Evidence level
- Human evidence
- Strong
- Animal evidence
- None
- Lab evidence
- None
- Registered trials
- 2
Sources
Research and educational information only. Not medical advice.